Evidence map›Paper›PMID 40567090›Full record

ArticleThe Canadian journal of urology2025

Quality of life and surgical treatment regret in patients with benign prostatic hypertrophy: a multicenter study.

Joshua Winograd, Rebecca Kindler, Cassidy Lleras, Alia Codelia-Anjum, Naeem Bhojani, Dean Elterman, Michael A Diefenbach, Daniel Ufearo, Katharine Kechejian, Siri Drangsholt and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in The Canadian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Joshua WinogradDepartment of Urology, Weill Cornell Medicine, New York City, NY 10021, USA.
Rebecca KindlerWestchester Medical Center, Department of Urology/Urogynecology, New York Medical College School of Medicine, Valhalla, NY 10595, USA.
Cassidy LlerasWestchester Medical Center, Department of Urology/Urogynecology, New York Medical College School of Medicine, Valhalla, NY 10595, USA.
Alia Codelia-AnjumDepartment of Urology, Northwell Health, Syosset, NY 11791, USA.
Naeem BhojaniDepartment of Urology, University of Montreal, Montreal, QC H3C 3J7, Canada.
Dean EltermanDivision of Urology, University of Toronto, Toronto, ON M5R 0A3, Canada.
Michael A DiefenbachDepartment of Urology, Northwell Health, Syosset, NY 11791, USA.
Daniel UfearoWestchester Medical Center, Department of Urology/Urogynecology, New York Medical College School of Medicine, Valhalla, NY 10595, USA.
Katharine KechejianWestchester Medical Center, Department of Urology/Urogynecology, New York Medical College School of Medicine, Valhalla, NY 10595, USA.
Siri DrangsholtWestchester Medical Center, Department of Urology/Urogynecology, New York Medical College School of Medicine, Valhalla, NY 10595, USA.
Bilal ChughtaiDepartment of Urology, Northwell Health, Syosset, NY 11791, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBenign prostatic hypertrophy (BPH) is a common condition affecting men later in life, significantly impacting quality of life (QOL). Surgical intervention is often pursued when medical management fails, but patient satisfaction with outcomes varies. Decisional regret can affect perceived success and patient satisfaction post-surgery. This study evaluates the relationship between post-surgical symptoms and decisional regret across BPH procedures.

methodsA prospective, multicenter cohort study included 54 patients undergoing BPH surgery between March 2023 and February 2024. Patients completed the International Prostate Symptom Score-QOL (IPSS-QOL) scale preoperatively and at least three months postoperatively, along with the Decision Regret Scale (DRS). Surgical types included Urolift, Greenlight Laser, Rezum, Aquablation, and transurethral resection of the prostate (TURP). A DRS score of ≥25 indicated significant regret. Changes in IPSS-QOL were correlated with DRS scores (Spearman's rho), and subgroup comparisons were conducted using Mann-Whitney U tests.

resultsThe average DRS score was 18.3, with 33% of patients reporting a DRS ≥25. Moderate correlations existed between quality of life (QOL) change (ρ = 0.34, p < 0.05) and total regret score. Minimally invasive surgical treatment (MISTs) patients demonstrated higher regret correlations than TURP. Lack of efficacy (75%), new symptoms (41%), and postoperative complications (25%) were the most common reasons for regret.

conclusionWhile BPH surgery generally improves symptoms, a substantial portion of patients experience decisional regret. This underscores the importance of preoperative counseling to establish realistic expectations and reduce regret. Further research should explore strategies to enhance shared decision-making and align patient expectations with possible surgical outcomes.

Indexed as

EmotionsPatient SatisfactionProstatectomyProstatic HyperplasiaQuality of LifeAgedAged, 80 and overCohort StudiesHumansMaleMiddle AgedProspective StudiesTransurethral Resection of ProstateTreatment OutcomeBPHprostatesurgery

Identifiers

PMID40567090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.